{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:40:45Z","timestamp":1793904045419,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"US Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["HHSD20002013M53964B"],"award-info":[{"award-number":["HHSD20002013M53964B"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.josat.2024.209310","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T21:17:05Z","timestamp":1707254225000},"page":"209310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Barriers to retention in medications for opioid use disorder treatment in real-world practice"],"prefix":"10.1016","volume":"160","author":[{"given":"Vanessa I.","family":"Villamil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherie R.","family":"Rooks-Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gery P.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.josat.2024.209310_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.josat.2024.209310_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108548","article-title":"Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting","volume":"131","author":"Bailey","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2024.209310_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention","volume":"25","author":"Beardsley","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209310_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-022-00299-1","article-title":"Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community","volume":"17","author":"Biondi","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2024.209310_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/08897077.2021.1967836","article-title":"Opioid treatment programs, telemedicine and COVID-19: A scoping review","volume":"43","author":"Chan","year":"2022","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2024.209310_bb0030","article-title":"County-level sociodemographic differences in availability of two medications for opioid use disorder\u2013United States, 2019","volume":"109495","author":"Corry","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209310_bb0035","series-title":"The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes from an 18-Month Study of Patients in Treatment for Opioid Use Disorder","author":"Dever","year":"2023"},{"issue":"12","key":"10.1016\/j.josat.2024.209310_bb0040","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care\u2013based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209310_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0740-5472(01)00185-4","article-title":"Transportation and retention in outpatient drug abuse treatment programs","volume":"21","author":"Friedmann","year":"2001","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.josat.2024.209310_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36298","article-title":"Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic","volume":"5","author":"Frost","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209310_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective","volume":"221","author":"Hall","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2024.209310_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2024.209310_bb0065","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1503\/cmaj.101715","article-title":"Overestimation of risk ratios by odds ratios in trials and cohort studies: Alternatives to logistic regression","volume":"184","author":"Knol","year":"2012","journal-title":"Cmaj"},{"key":"10.1016\/j.josat.2024.209310_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2024.209310_bb0075","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis","volume":"24","author":"Ma","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"7","key":"10.1016\/j.josat.2024.209310_bb0080","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/appi.ps.201700363","article-title":"Three-year retention in buprenorphine treatment for opioid use disorder among privately insured adults","volume":"69","author":"Manhapra","year":"2018","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/j.josat.2024.209310_bb0085","doi-asserted-by":"crossref","first-page":"e223821","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209310_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2019.07.010","article-title":"Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?","volume":"105","author":"Meinhofer","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2024.209310_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ajad.12896","article-title":"Long-term retention in an outpatient behavioral health clinic with buprenorphine","volume":"28","author":"Montalvo","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2024.209310_bb0100","series-title":"Behavioral health 2016\u20132017: Technical report","author":"National Quality Forum (NQF)","year":"2017"},{"issue":"7","key":"10.1016\/j.josat.2024.209310_bb0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","article-title":"Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multi-state population","volume":"55","author":"Saloner","year":"2017","journal-title":"Medical Care"},{"issue":"4","key":"10.1016\/j.josat.2024.209310_bb0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsat.2009.05.003","article-title":"Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year","volume":"37","author":"Soeffing","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209310_bb0115","series-title":"Drug overdose deaths in the United States, 2001\u20132021. NCHS data brief(457)","first-page":"1","author":"Spencer","year":"2022"},{"key":"10.1016\/j.josat.2024.209310_bb0120","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2024.209310_bb0125","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"issue":"2","key":"10.1016\/j.josat.2024.209310_bb0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ije\/dyaa213","article-title":"Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: Review and recommendations","volume":"50","author":"Tennant","year":"2021","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.josat.2024.209310_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/epirev\/mxaa001","article-title":"Adherence to and retention in medications for opioid use disorder among adolescents and young adults","volume":"42","author":"Viera","year":"2020","journal-title":"Epidemiologic reviews."},{"issue":"2","key":"10.1016\/j.josat.2024.209310_bb0140","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209310_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"Journal of substance abuse treatment."},{"key":"10.1016\/j.josat.2024.209310_bb0150","series-title":"World Health Organization","author":"WHO\/UNODC\/UNAIDS position paper: Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention","year":"2004"},{"issue":"2","key":"10.1016\/j.josat.2024.209310_bb0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2024.209310_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108686","article-title":"Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data","volume":"136","author":"Zhang","year":"2022","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:52:54Z","timestamp":1757433174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"alternative-id":["S2949875924000225"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209310","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to retention in medications for opioid use disorder treatment in real-world practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209310"}}